Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral Pharmacology of Orally Administered THC and D-limonene
NCT06378957Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Feb 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Limonene (6 arms), sponsored by Johns Hopkins University. Primary endpoint: Subjective Drug Effect at 8 hours. Started Feb 2025; status: recruiting.
02
Drugs
Limonene
Beyond the preview
Go deeper on NCT06378957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378957.